Cedric Francois - Chief Executive Officer, Director at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Cedric Francois - trading volume in the past year for Apellis Pharmaceuticals, Inc.

Holdings reported by Cedric Francois for Apellis Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 654K $43M $65.68 Mar 1, 2024 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023)
Common Stock 533K $35M $65.68 Mar 1, 2024 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2)
Common Stock 314K $20.6M $65.68 Mar 1, 2024 Direct
Common Stock 300K $19.7M $65.68 Mar 1, 2024 Indirect Owner (The Francois Grossi Trust)
Common Stock 234K $15.4M $65.68 Mar 1, 2024 Indirect Owner (The Francois-DuBois Educational Trust)
Stock Option (Right to Buy) 176K $11.6M $66.30 Mar 1, 2024 Direct Common Stock

Transactions reported by Cedric Francois for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.